Get started
Author

María Luisa Manzano

Observed names: M L Manzano, M Manzano, M. L. Manzano, M. L. Manzano-Alonso, M. Luisa Manzano, M. Manzano, M.L. Manzano, Maria Luisa Manzano, Maria Luisa Manzano Alonso, María L. Manzano, María Luisa Manzano Alonso, María Luisa Manzano-Alonso
Observed institutions: Universidad Complutense de Madrid, Novo Nordisk (Denmark), Medical University of Graz, Hospital Universitario 12 De Octubre, Hospital Universitario Fundación Jiménez Díaz, Fundación para el Estudio de las Hepatitis Virales, Fundación Renal Española, Instituto de Investigación Sanitaria Fundación Jiménez Díaz
ORCID: 0000-0002-5062-364X
Observed ORCID: 0000-0002-5062-364X
OpenAlex ID: A5035458112
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
2021 · Georg Semmler, Elias Laurin Meyer, et al. · Journal of Hepatology · 139
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
2017 · Juan Manuel Pascasio, Carmen Vinaixa, et al. · Journal of Hepatology · 132
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis
2020 · Sonia Alonso López, María Luisa Manzano, et al. · Hepatology · 98
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
2017 · María Buti, María L. Manzano, et al. · PLoS ONE · 98
PDF
Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
2011 · María Luisa Manzano-Alonso · World Journal of Gastroenterology · 96
PDF
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma
2017 · Mar Riveiro-Barciela, David Tabernero, et al. · Digestive Diseases and Sciences · 72
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients
2015 · I. Fernández, C. Loinaz, et al. · Transplant Infectious Disease · 54
Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands
2000 · Antonio Madejón, Maria Luisa Manzano, et al. · Journal of Hepatology · 25
Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis
2001 · E. Rodríguez-Iñigo, J. Bartolomé, et al. · Blood Coagulation & Fibrinolysis · 23
Enfermedad celíaca y síndrome de Budd-Chiari: una asociación infrecuente
2002 · J. Manzanares, P. Urruzuno, et al. · Gastroenterología y Hepatología · 21
Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals
2021 · María Sánchez‐Azofra, Inmaculada Fernández, et al. · Liver International · 20
Presence of TTV DNA in serum, liver and peripheral blood mononuclear cells from patients with chronic hepatitis
2000 · J. M. López‐Alcorocho, L. F. Mariscal, et al. · Journal of Viral Hepatitis · 19
[Eosinophilic cholecystitis: an infrequent cause of cholecystectomy].
1997 · P Sánchez-Pobre, F López-Ríos Moreno, et al. · PubMed · 18
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
2022 · Markus Cornberg, Adriana Ahumada, et al. · Advances in Therapy · 16
PDF
Acute hepatitis C in Spain: a retrospective study of 131 cases
2012 · Ramón Pérez-Álvarez, Javier García-Samaniego, et al. · Revista Española de Enfermedades Digestivas · 14
PDF
A pilot study of β-interferon for treatment of patients with chronic hepatitis B who failed to respond to α-interferon
2002 · Raquel Muñoz, Gregorio Castellano, et al. · Journal of Hepatology · 13
Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen
2014 · Nuria Dominguez, Maria Luisa Manzano, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk
2000 · M. L. Manzano, C. Arocena, et al. · Blood Coagulation & Fibrinolysis · 12
Assessment of the usefulness of endoscopic signs in Helicobacter pylori associated gastritis.
1997 · M C Yela, M L Manzano, et al. · PubMed · 12
Idiopathic thrombocytopenic purpura and pancytopenia in a patient with Crohn's disease: a new association.
1996 · M L Manzano, C Yela, et al. · PubMed · 12
Diagnostic accuracy of liver and spleen stiffness measured by fibroscan® in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals
2020 · Carolina Muñoz-Codoceo, Maria Amo, et al. · Gastroenterología y Hepatología · 10
Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort
2016 · J. Crespo, I. Fenandez, et al. · Journal of Hepatology · 10
GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients
1999 · María Cabrerizo, Javier Bartolomé, et al. · Kidney International · 8
Asociación entre hiperhomocisteinemia y esteatosis hepática en pacientes con hepatitis crónica C
2010 · Consuelo Fernández-Miranda, María Luisa Manzano, et al. · Medicina Clínica · 7
Interferon (INF)-Free Antiviral Therapy in Cirrhotic Patients Infected with Hepatitis C on the Waiting List for Liver Transplantation. Efficacy and Impact on Delisting and Liver Function
2016 · J.M. Pascasio, C. Vinaixa, et al. · Journal of Hepatology · 5
Works count: 70
Citation count: 991
H-index: 14
I10-index: 22
Year
Topic
Type